Sébastien Jacquet
AbbVie (United States) · 24 works · 1,135 citations · h-index 14
Top works
- Ectopic β-chain of ATP synthase is an apolipoprotein A-I receptor in hepatic HDL endocytosis
- Glycogen Synthase Kinase-3 Inactivation Is Not Required for Ischemic Preconditioning or Postconditioning in the Mouse
- The nucleotide receptor P2Y13 is a key regulator of hepatic High-Density Lipoprotein (HDL) endocytosis
- Identification of Cardiac Myosin-binding Protein C as a Candidate Biomarker of Myocardial Infarction by Proteomics Analysis
- Activation of p38 Mitogen-Activated Protein Kinase Contributes to the Early Cardiodepressant Action of Tumor Necrosis Factor
- New insight on the molecular mechanisms of high-density lipoprotein cellular interactions
- A Chemical Genetic Approach Reveals That p38α MAPK Activation by Diphosphorylation Aggravates Myocardial Infarction and Is Prevented by the Direct Binding of SB203580
- The Role of RIP2 in p38 MAPK Activation in the Stressed Heart
- The activation of p38alpha, and not p38beta, mitogen-activated protein kinase is required for ischemic preconditioning
- Opioid receptor blockade reduces Fas-induced hepatitis in mice
- The relationship between p38 mitogen-activated protein kinase and AMP-activated protein kinase during myocardial ischemia
- Pharmacological postconditioning effect of muramyl dipeptide is mediated through RIP2 and TAK1
- Discovery of novel quinoline sulphonamide derivatives as potent, selective and orally active RORγ inverse agonists
- Inhibition of Interleukin-23–Mediated Inflammation with a Novel Small Molecule Inverse Agonist of RORγt
- The role of RIP2 in p38 MAPK activation in the stressed heart
- Research Article The nucleotide receptor P2Y 13 is a key regulator of hepatic High-Density Lipoprotein (HDL) endocytosis
- « ATP synthase/apolipoprotéine A-I : un nouveau couple contre l'athérosclérose ? / ATP synthase and apolipoprotein synthase: new players in atherosclerosis »
- The relationship between P38–MAPK and AMPK during myocardial ischaemia
- Les récepteurs aux HDL dans le transport-retour du cholestérol
- HDL, ATP synthase, récepteur nucléotidique P2y13 =un trio de choc contre l'athérosclérose?